Skip to main content

Advertisement

Table 5 WA and STD Productivity Loss and Indirect Costs in Propensity Score Matched Cohorts with WA and STD Eligibility

From: Productivity loss and indirect costs associated with cardiovascular events and related clinical procedures

Measure Patients with WA and STD Eligibility
With CVERP Without CVERP p-value
N = 3,362 N = 3,362  
n/mean %/SD n/mean %/SD  
During the 1st month of follow-up:      
Patients reporting WA/STD (n, %) 2,980 88.6 2,591 77.1 <.001
Monthly hours lost due to WA/STD (mean, SD) 78.7 63.5 22.4 30.3 <.001
Indirect costs associated with WA/STD (mean, SD) $1,744 $1,293 $624 $785 <.001
Patients with ≥ 1 year of follow-up (n, %) 2,030 60.4 2,249 66.9  
During the 1st year of follow-up:      
Patients reporting WA/STD (n, %) 1,917 94.4 2,093 93.1 0.07
Monthly hours lost due to WA/STD (mean, SD) 35.0 29.3 21.4 14.1 <.001
Indirect costs associated with WA/STD (mean, SD) $847 $572 $610 $374 <.001
Patients with ≥ 2 years of follow-up (n, %) 1,184 35.2 1,364 40.6  
During the 2nd year of follow-up:      
Patients reporting WA/STD (n, %) 1,088 91.9 1,294 94.9 0.002
Monthly hours lost due to WA/STD (mean, SD) 22.2 18.0 21.2 13.7 0.12
Indirect costs associated with WA/STD (mean, SD) $590 $389 $590 $337 0.99
Patients with ≥ 3 years of follow-up (n, %) 622 18.5 759 22.6  
During the 3rd year of follow-up:      
Patients reporting WA/STD (n, %) 581 93.4 723 95.3 0.14
Monthly hours lost due to WA/STD (mean, SD) 21.3 16.2 20.7 12.9 0.44
Indirect costs associated with WA/STD (mean, SD) $561 $359 $568 $305 0.68
  1. CVERP: cardiovascular events and related clinical procedures; SD: standard deviation; STD: short-term disability; WA: workplace absenteeism